Ruud van Beek

2.6k citations

23 papers · 2.0k indexed · 1 hit paper · h-index 19

Co-authors: Guus F. Rimmelzwaan Albert D. M. E. Osterhaus Eric C. J. Claas J.C. de Jong Robert G. Webster Dennis A. Senne K. F. Shortridge Scott Krauss
Topics: Influenza Virus Research Studies (20 papers)Respiratory viral infections research (15 papers)Animal Disease Management and Epidemiology (5 papers)
Cited by: Agronomy and Crop Science Epidemiology Infectious Diseases
Journals: The Lancet Nature Immunology Journal of Virology
Partner nations: Netherlands United States Mongolia

In The Last Decade

Ruud van Beek

23 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus

1998 1.1k citations Eric C. J. Claas, Albert D. M. E. Osterhaus et al. The Lancet profile →

Peers

Countries citing papers authored by Ruud van Beek

Since Specialization

Citations

This map shows the geographic impact of Ruud van Beek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruud van Beek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruud van Beek more than expected).

Fields of papers citing papers by Ruud van Beek

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruud van Beek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruud van Beek. The network helps show where Ruud van Beek may publish in the future.

Co-authorship network of co-authors of Ruud van Beek

This figure shows the co-authorship network connecting the top 25 collaborators of Ruud van Beek. A scholar is included among the top collaborators of Ruud van Beek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruud van Beek. Ruud van Beek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A prospective, double-blind, randomized, placebo-controlled study on the efficacy and safety of influenza vaccination in myasthenia gravis 2019 ·Vaccine ·(unknown),Martijn R. Tannemaat,(unknown),Robert H.P. de Meel,Jaap Bakker,Ruud van Beek,Frank P. Kroon,Guus F. Rimmelzwaan,Jan J.G.M. Verschuuren	25
2	Diet May Drive Influenza A Virus Exposure in African Mammals 2019 ·The Journal of Infectious Diseases ·(unknown),Erwin de Bruin,Mathias Franz,Ortwin Aschenborn,Guus F. Rimmelzwaan,Ruud van Beek,Marion Koopmans,Alex D. Greenwood,Gábor Á. Czirják	10
3	Neuraminidase-mediated haemagglutination of recent human influenza A(H3N2) viruses is determined by arginine 150 flanking the neuraminidase catalytic site 2017 ·Journal of General Virology ·Ramona Mögling,Mathilde Richard,Stefan van der Vliet,Ruud van Beek,Eefje J. A. Schrauwen,Monique I. Spronken,Guus F. Rimmelzwaan,Ron A. M. Fouchier	33
4	ViroSpot microneutralization assay for antigenic characterization of human influenza viruses 2016 ·Vaccine ·Carel A. van Baalen,Rienk E. Jeeninga,(unknown),(unknown),Ruud van Beek,Marion Koopmans,Guus F. Rimmelzwaan	46
5	Antigenic Maps of Influenza A(H3N2) Produced With Human Antisera Obtained After Primary Infection 2015 ·The Journal of Infectious Diseases ·Judith M. Fonville,Pieter L. A. Fraaij,Gerrie de Mutsert,Samuel Wilks,Ruud van Beek,Ron A. M. Fouchier,Guus F. Rimmelzwaan	33
6	A central role for Notch in effector CD8+ T cell differentiation 2014 ·Nature Immunology ·Ronald A. Backer,Christina Helbig,Rebecca Gentek,Andrew Kent,Brian J. Laidlaw,Claudia X. Dominguez,(unknown),Stella E. van Trierum,Ruud van Beek,Guus F. Rimmelzwaan,Anja ten Brinke,(unknown),Antoine H. C. van Kampen,Susan M. Kaech,J. Magarian Blander,Klaas P. J. M. van Gisbergen,Derk Amsen	93
7	Molecular Assays for Quantitative and Qualitative Detection of Influenza Virus and Oseltamivir Resistance Mutations 2013 ·Journal of Molecular Diagnostics ·Erhard van der Vries,(unknown),Anne van der Linden,(unknown),Jolanda Maaskant,Ralph Stadhouders,Ruud van Beek,Guus F. Rimmelzwaan,Albert D. M. E. Osterhaus,Charles A. Boucher,Martin Schutten	27
8	The influence of influenza virus infections on the development of tuberculosis 2013 ·Tuberculosis ·Roelof A. de Paus,Reinout van Crevel,Ruud van Beek,Edhyana Sahiratmadja,Bachti Alisjahbana,Sangkot Marzuki,Guus F. Rimmelzwaan,Jaap T. van Dissel,Tom H. M. Ottenhoff,Esther van de Vosse	26
9	Genomewide Analysis of Reassortment and Evolution of Human Influenza A(H3N2) Viruses Circulating between 1968 and 2011 2013 ·Journal of Virology ·Kim B. Westgeest,Colin A. Russell,Xudong Lin,Monique I. Spronken,Theo M. Bestebroer,Justin Bahl,Ruud van Beek,Eugene Skepner,Rebecca Halpin,J.C. de Jong,Guus F. Rimmelzwaan,Albert D. M. E. Osterhaus,Derek J. Smith,David E. Wentworth,Ron A. M. Fouchier,Miranda de Graaf	122
10	Genetic evolution of the neuraminidase of influenza A (H3N2) viruses from 1968 to 2009 and its correspondence to haemagglutinin evolution 2012 ·Journal of General Virology ·Kim B. Westgeest,Miranda de Graaf,Mathieu Fourment,Theo M. Bestebroer,Ruud van Beek,Monique I. Spronken,J.C. de Jong,Guus F. Rimmelzwaan,Colin A. Russell,Albert D. M. E. Osterhaus,Gavin J. D. Smith,Derek J. Smith,Ron A. M. Fouchier	66
11	Response to influenza virus vaccination during chemotherapy in patients with breast cancer 2011 ·Annals of Oncology ·A. Meerveld-Eggink,Okke de Weerdt,Ankie M.T. van der Velden,Maartje Los,Annette W.G. van der Velden,Jacqueline M. Stouthard,Marten R. Nijziel,Matthijs Westerman,Aart Beeker,Ruud van Beek,Guus F. Rimmelzwaan,Ger T. Rijkers,Douwe H. Biesma	45
12	Immunogenicity, Boostability, and Sustainability of the Immune Response after Vaccination against Influenza A Virus (H1N1) 2009 in a Healthy Population 2011 ·Clinical and Vaccine Immunology ·Elisabeth G. W. Huijskens,John W. A. Rossen,Paul Mulder,Ruud van Beek,(unknown),(unknown),Guus F. Rimmelzwaan,Marion Koopmans,Marcel F. Peeters	34
13	A single dose of an ISCOM influenza vaccine induces long-lasting protective immunity against homologous challenge infection but fails to protect Cynomolgus macaques against distant drift variants of influenza A (H3N2) viruses 2001 ·Vaccine ·Guus F. Rimmelzwaan,Marianne Baars,Geert van Amerongen,Ruud van Beek,Albert D. M. E. Osterhaus	37
14	G Protein Variation in Respiratory Syncytial Virus Group A Does Not Correlate with Clinical Severity 2000 ·Journal of Clinical Microbiology ·A. H. Brandenburg,Ruud van Beek,HA Moll,Albert D. M. E. Osterhaus,Eric C. J. Claas	29
15	Characterization of adaptation of an avian influenza A (H5N2) virus to a mammalian host. 2000 ·PubMed ·(unknown),A. S. Lipatov,Ruud van Beek,A. K. Gitelman,Albert D. M. E. Osterhaus,Eric C. J. Claas	28
16	Influenza virus subtype cross-reactivities of haemagglutination inhibiting and virus neutralising serum antibodies induced by infection or vaccination with an ISCOM-based vaccine 1999 ·Vaccine ·Guus F. Rimmelzwaan,Marianne Baars,Ruud van Beek,(unknown),J.C. de Jong,Eric C. J. Claas,Albert D. M. E. Osterhaus	26
17	Human influenza A H5N1 virus related to a highly pathogenic avian influenza virusbreakdown → 1998 ·The Lancet ·Eric C. J. Claas,Albert D. M. E. Osterhaus,Ruud van Beek,J.C. de Jong,Guus F. Rimmelzwaan,Dennis A. Senne,Scott Krauss,K. F. Shortridge,Robert G. Webster	1150
18	Induction of protective immunity against influenza virus in a macaque model: comparison of conventional and iscom vaccines. 1997 ·Journal of General Virology ·Guus F. Rimmelzwaan,Ruud van Beek,Geert van Amerongen,(unknown),(unknown),Albert D. M. E. Osterhaus,Marianne Baars	82
19	Type-specific identification of influenza viruses A, B and C by the polymerase chain reaction 1992 ·Journal of Virological Methods ·Eric C. J. Claas,M Sprenger,(unknown),Ruud van Beek,Wim Quint,(unknown)	78
20	Immunoglobulin G, A and M response to influenza vaccination in different age groups: effects of priming and boosting 1986 ·Journal of Hygiene ·W.E.P. Beyer,J. T. M. van der Logt,Ruud van Beek,N. Masurel	17

About Ruud van Beek

Ruud van Beek is a scholar working on Epidemiology, Agronomy and Crop Science and Infectious Diseases, having authored 23 papers that have together received 2.0k indexed citations. Recurring topics across this work include Influenza Virus Research Studies (20 papers), Respiratory viral infections research (15 papers) and Animal Disease Management and Epidemiology (5 papers). The work is most often cited by research in Agronomy and Crop Science (636 citations), Epidemiology (1.7k citations) and Infectious Diseases (803 citations). Ruud van Beek has collaborated with scholars based in Netherlands, United States and Mongolia. Frequent co-authors include Guus F. Rimmelzwaan, Albert D. M. E. Osterhaus, Eric C. J. Claas, J.C. de Jong, Robert G. Webster, Dennis A. Senne, K. F. Shortridge, Scott Krauss, Marianne Baars and Ron A. M. Fouchier. Their work appears in journals such as The Lancet, Nature Immunology and Journal of Virology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact